HealthTree News

October 29, 2024

If you are a person with advanced-stage follicular lymphoma who is starting their first treatment, learn how certain therapy options compare.

October 22, 2024

Is it safe for relapsed/refractory non-Hodgkin lymphoma patients, including DLBCL, to receive CAR T-cell therapy in an outpatient setting?

October 16, 2024

Learn which key factors influence the long-term outcomes of follicular lymphoma patients.

October 15, 2024

Dr. Mark Roschewski shared with HealthTree about his presentation at ASH 2023 on the results of a regimen known as ViPOR, designed for patients with R/R DLBCL.

October 15, 2024

After three years since its original Phase III trial, lisocabtagene maraleucel (liso-cel) is still proving effective for relapsed/refractory DLBCL patients.

October 11, 2024

Are your blood counts low? It may be pancytopenia. Learn about its causes and treatments.

October 11, 2024

What are bispecific antibodies, and when are they used to treat follicular lymphoma? Learn answers to these questions and more!

October 08, 2024

Diffuse Large B-cell Lymphoma (DLBCL) can begin in or spread to the lungs. The signs and symptoms are non-specific, which can make diagnosis difficult.

October 01, 2024

Understanding CAR T-Cell Therapy and the Armored CAR T-Cell Trial

September 30, 2024

Learn about clinical trials to open the door to accessing innovative cancer treatments.